Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer.
Tingdong LiFugui LiXiaoyi GuoCongming HongXia YuBiaohua WuShifeng LianLiuwei SongJiabao TangShunhua WenKaimin GaoMengling HaoWeimin ChengYingying SuShiyin ZhangShoujie HuangMujin FangYingbin WangMun-Hon NgHong-Lin ChenWenxin LuoShengxiang GeJun ZhangNingshao XiaMingfang JiPublished in: The New England journal of medicine (2023)
Our results suggest that P85-Ab is a promising novel biomarker for nasopharyngeal carcinoma screening, with higher sensitivity, specificity, and positive predictive value than the standard two-antibody method. (Funded by the National Key Research and Development Program of China and others; ClinicalTrials.gov number, NCT04085900.).